The short version
- What the evidence isRussian and Soviet clinical literature, where it is classed as an 'actinoprotector' — a drug category that essentially does not exist outside that research tradition.
- What to watchPersistent insomnia or edginess.
How Bemethyl works
A Russian 'actinoprotector' — the drug class built around improving tolerance to physical work under hypoxia. Its described action is on mitochondrial protein synthesis: rather than stimulating output acutely like a beta-agonist, it is reported to raise the enzymatic capacity for gluconeogenesis and aerobic metabolism over a course of days.
Bemethyl is 2-ethylthiobenzimidazole, usually supplied as the hydrobromide salt, and the sulfur atom is the whole molecule. A benzimidazole ring with an ethylthio group at position 2: a small, lipophilic, weakly basic heterocycle of about 178 Da as the free base.
It belongs to a drug class that has no equivalent outside the Russian-language literature. An actoprotector is defined by what it is supposed to do: maintain physical work capacity under hypoxia without stimulating the central nervous system. Oliynyk 2012 is the English-language review of the class and it is the right place to start, because the framing matters: this is not a stimulant, and a page that treats it as one has already made the central error.
- Oral
On the goal map: Exercise mimetics & mitochondrial biogenesis (Endurance & work capacity)
Where to get Bemethyl
When a vetted partner does, the link and code go here.
Research on Bemethyl5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Human (Russian/Soviet clinical literature); almost none of it replicated outside that school.
Human clinical evidence
Russian and Soviet clinical literature, where it is classed as an 'actinoprotector' — a drug category that essentially does not exist outside that research tradition. Studied for physical work capacity, hypoxia tolerance and recovery.
Almost none of it has been replicated independently. Single-group designs, one research school, one language. See [[evidence-framing-rule]] — that is an absence of evidence, not evidence of absence, and the two get confused constantly with this class.
Correlative data
It sits in the same evidence position as the Khavinson bioregulators already in the Vault: decades of use inside one system, and a near-total gap in the Western literature. Read it the same way.
How the mechanism reads
Described as acting on mitochondrial protein synthesis — raising the enzymatic capacity for gluconeogenesis and aerobic metabolism rather than stimulating output acutely.
MechanisticIf the mechanism is adaptive rather than stimulant.
Mechanistic
Sources
- Belinskaia DA, et al. Investigation of Bemethyl Biotransformation Pathways by Combination of LC-MS/HRMS and In Silico Methods. International Journal of Molecular Sciences 2021 · PMID 34445727
- Oliynyk S, Oh S. The pharmacology of actoprotectors: practical application for improvement of mental and physical performance. Biomolecules and Therapeutics 2012 · PMID 24009833
- Kibal'chich DA, et al. [Pharmacokinetics of domestic actoprotector drug Metaprot in healthy volunteers]. Eksperimentalnaia i Klinicheskaia Farmakologiia 2011 · PMID 21870773
- Boiko SS, et al. [Bemetil pharmacokinetics in an experiment on rats]. Farmakologiia i Toksikologiia 1987 · PMID 3691781
- Kobylianskii VI, et al. [Effect of bemithyl (bemactor) on the bronchial epithelium regeneration and the main protector mechanisms of the respiratory system in chronic inflammation]. Tsitologiia 1999 · PMID 10420471
- Lobzin VS, et al. [The use of bemitil in patients with progressive muscular dystrophies]. Likars'ka Sprava 1992 · PMID 1441389
Bemethyl safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Liver disease, because clearance runs through glutathione-linked pathways.
- Insomnia or an anxiety disorder, as the compound is mildly activating.
- Pregnancy, with no Western safety work on file.
- Under 18, because this actoprotector was only studied in adult workers and athletes.
What’s expected
- More tolerance to physical work in low oxygen, per Russian actoprotector studies.
- A mild stimulating feel without a beta-agonist style spike.
- Headache in some users.
Watch for
- Persistent insomnia or edginess.
- Nausea with upper abdominal pain.
- Yellowing of the skin or eyes.
Labs that tell you it’s working
- Comprehensive Metabolic Panel: liver enzymes, because glutathione-dependent clearance is the burden.
- Cortisol: actoprotectors are reported to blunt the stress-axis response, so this tests the claim.
Russian actoprotector described as raising mitochondrial and ribosomal protein synthesis under hypoxic stress; Western toxicology is thin. PMID 24009833
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Bemethyl FAQ3 common questions
- Is Bemethyl approved for human use?
- No. Bemethyl is a research compound.
- Which labs show whether it's doing anything?
- Comprehensive Metabolic Panel; Cortisol: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Bemethyl: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



